🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Low Grade Serous Ovarian Carcinoma

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer NCT05872204Phase 212 sites📍 Liège📍 Ghent📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Abemaciclib, Letrozole Study of NTB-928 in R/R OC NCT07690189Phase 14 sites📍 Birmingham📍 Omaha📍 Lake Success TeneoSeven, Inc. · Tests: NTB-928 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites📍 Birmingham📍 Boston📍 Boston Regeneron Pharmaceuticals · Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites📍 Graz📍 Graz📍 Innsbruck Swiss GO Trial Group · Tests: Letrozole 2.5mg, Placebo A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer NCT06394804Phase 28 sites📍 Atlanta📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: Avutometinib, Defactinib, Letrozole A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer NCT06072781Phase 3106 sites📍 Phoenix📍 Little Rock📍 Los Angeles Verastem, Inc. · Tests: avutometinib, Defactinib, Pegylated liposomal doxorubicin, Paclitaxel, Letrozole Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) NCT05601700Phase 319 sites📍 Arezzo📍 Ponderano📍 Belluno Ente Ospedaliero Ospedali Galliera · Tests: Letrozole tablets, carboplatin AUC 5 and paclitaxel 175 mg/m2 Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer NCT05113368Phase 21 site📍 Cleveland Sarah K. Lynam MD · Tests: Regorafenib, Fulvestrant Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors NCT00488878n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Electronic Health Record Review Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer NCT05950464Phase 114 sites📍 Augusta📍 Chicago📍 Iowa City National Cancer Institute (NCI) · Tests: BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance I…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy